Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid structure that surrounds bacteria, providing mechanical protection, maintaining cell shape, and protecting against osmotic damage. The primary structural component is peptidoglycan (also called murein), a mesh-like polymer composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues cross-linked by short peptide chains. Gram-positive bacteria have a thick, multilayered peptidoglycan wall (up to 90% of the cell wall) with embedded teichoic acids, while Gram-negative bacteria have a thin peptidoglycan layer sandwiched between an inner cytoplasmic membrane and an outer membrane containing lipopolysaccharides. The bacterial cell wall has been one of the most successful antibiotic targets since the discovery of penicillin, as it is essential for bacterial survival but absent in mammalian cells. The term "nuclear material" in this context likely refers to the bacterial nucleoid, which contains the bacterial chromosome, though this is poorly defined in the target name. This designation combines multiple distinct cellular components and would benefit from separation into more specific targets such as "peptidoglycan biosynthesis," "penicillin-binding proteins," or specific enzymes in the cell wall synthesis pathway.
Inhibition of peptidoglycan cross-linking (β-lactams target penicillin-binding proteins) - Inhibition of peptidoglycan biosynthesis - Disruption of cell wall precursor lipid II - Enzymatic degradation of peptidoglycan (lysozyme) - Inhibition of specific biosynthetic enzymes (MurA, MurB, MurC, MurD, MurE, MurF, Alr, Ddl, MurI, MurG)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell walls and nuclear material.